Published in
Elsevier, Lung Cancer, (124), p. 130-134, 2018
DOI: 10.1016/j.lungcan.2018.07.030
Links
Tools
Crizotinib treatment for patients with EGFR mutation positive NSCLC that acquire cMET amplification after EGFR TKI therapy results in short-lived and heterogeneous responses
Journal article published in 2018 by
Bianca van Veggel,
Adrianus J. de Langen,
Sayed Hashemi 
,
Kim Monkhorst,
Efraim H. Rosenberg,
Daniëlle A. M. Heideman,
Teodora Radonic ,
Egbert F. Smit
,
Kim Monkhorst,
Efraim H. Rosenberg,
Daniëlle A. M. Heideman,
Teodora Radonic ,
Egbert F. Smit
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 